• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特异性多巴胺D2受体激动剂LY171555在清醒大鼠中的升压作用机制

Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat.

作者信息

Nagahama S, Chen Y F, Lindheimer M D, Oparil S

出版信息

J Pharmacol Exp Ther. 1986 Mar;236(3):735-42.

PMID:2869141
Abstract

Administration of LY171555, a specific dopamine D2 receptor agonist, (10-1000 micrograms/kg i.v.) produced dose-related increases in mean arterial pressure in conscious Sprague-Dawley rats. Pretreatment with metoclopramide (5 mg/kg i.v.) abolished the pressor action of LY171555, whereas pretreatment with domperidone (2.5 mg/kg i.v.) and propranolol (10 mg/kg i.p.) did not affect the pressor action of LY171555. The vasopressor antagonist of arginine vasopressin (AVP), d(CH2)5Tyr(Me)AVP (10 micrograms/kg i.v.) and phenoxybenzamine (1 mg/kg i.v.) partly blocked and hexamethonium (25 mg/kg i.v.) enhanced the pressor action of LY171555. After combined treatment with both d(CH2)5Tyr(Me)AVP and phenoxybenzamine, LY171555 induced a depressor response which was completely blocked by pretreatment with domperidone. LY171555 administration induced a rapid, short-acting depressor response followed by a pressor response in conscious adrenomedullectomized Sprague-Dawley rats which was smaller in magnitude than that seen in intact Sprague-Dawley rats. LY171555 administration increased plasma norepinephrine, epinephrine and AVP in conscious Sprague-Dawley rats. These results suggest that the pressor action of LY171555 in conscious rats is dependent on activation of sympathetic outflow and AVP release through the central D2 dopaminergic system and that the central pressor effects of LY171555 could mask a depressor effect of LY171555 at the peripheral D2 dopamine receptor.

摘要

给清醒的斯普拉格 - 道利大鼠静脉注射特定的多巴胺D2受体激动剂LY171555(10 - 1000微克/千克),可使平均动脉压出现剂量相关的升高。静脉注射甲氧氯普胺(5毫克/千克)预处理可消除LY171555的升压作用,而静脉注射多潘立酮(2.5毫克/千克)和腹腔注射普萘洛尔(10毫克/千克)预处理则不影响LY171555的升压作用。精氨酸加压素(AVP)的血管升压拮抗剂d(CH2)5Tyr(Me)AVP(10微克/千克静脉注射)和酚苄明(1毫克/千克静脉注射)可部分阻断LY171555的升压作用,而六甲铵(25毫克/千克静脉注射)则增强其升压作用。在联合使用d(CH2)5Tyr(Me)AVP和酚苄明进行治疗后,LY171555诱导出降压反应,该反应可被多潘立酮预处理完全阻断。给清醒的肾上腺切除的斯普拉格 - 道利大鼠注射LY171555会先引起快速、短效的降压反应,随后出现升压反应,但其升压幅度小于完整的斯普拉格 - 道利大鼠。给清醒的斯普拉格 - 道利大鼠注射LY171555会使血浆去甲肾上腺素、肾上腺素和AVP升高。这些结果表明,LY171555在清醒大鼠中的升压作用依赖于通过中枢D2多巴胺能系统激活交感神经传出和AVP释放,并且LY171555的中枢升压作用可能掩盖其在外周D2多巴胺受体上的降压作用。

相似文献

1
Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat.特异性多巴胺D2受体激动剂LY171555在清醒大鼠中的升压作用机制
J Pharmacol Exp Ther. 1986 Mar;236(3):735-42.
2
Mechanism of the depressor action of LY171555, a selective dopamine D2 receptor agonist, in the anesthetized rat.选择性多巴胺D2受体激动剂LY171555在麻醉大鼠体内的降压作用机制
J Pharmacol Exp Ther. 1986 Nov;239(2):426-32.
3
Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats.血管加压素在选择性多巴胺D2受体激动剂LY171555心血管效应中的作用:清醒Brattleboro大鼠和长 Evans 大鼠的研究
J Pharmacol Exp Ther. 1987 Jul;242(1):143-51.
4
Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.在清醒的醋酸脱氧皮质酮/氯化钠高血压大鼠中,对特异性多巴胺D2受体激动剂喹吡罗的升压反应迟钝与心房利钠肽释放有关。
J Pharmacol Exp Ther. 1988 Aug;246(2):485-92.
5
Effect of quinpirole, a specific dopamine DA2 receptor agonist on the sympathoadrenal system in dogs.特异性多巴胺DA2受体激动剂喹吡罗对犬交感肾上腺系统的作用
J Pharmacol Exp Ther. 1990 Feb;252(2):770-7.
6
Continuous intravenous infusion of LY171555, a potent selective D2 receptor agonist, lowers blood pressure in the conscious rat.
Pharmacology. 1987;35(4):194-202. doi: 10.1159/000138311.
7
Enhanced response to the inhibitory action of LY171555, a dopamine D2-agonist, on in vivo striatal dopamine release in DOCA/NaCl-hypertensive rats.对多巴胺D2激动剂LY171555对去氧皮质酮/氯化钠高血压大鼠体内纹状体多巴胺释放的抑制作用的反应增强。
Brain Res. 1987 Jan 6;400(2):225-31. doi: 10.1016/0006-8993(87)90621-4.
8
Blood pressure effects of intravenous apomorphine in conscious deoxycorticosterone-acetate salt-hypertensive rats.静脉注射阿扑吗啡对清醒的醋酸脱氧皮质酮盐高血压大鼠血压的影响。
J Cardiovasc Pharmacol. 2003 Dec;42(6):772-81. doi: 10.1097/00005344-200312000-00012.
9
Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.培高利特对大鼠血压和心率降低作用的药理、血流动力学及自主神经系统机制。
J Pharmacol Exp Ther. 1984 Mar;228(3):779-91.
10
Dopamine D2 receptors in the posterior region of the nucleus tractus solitarius mediate the central pressor action of quinpirole (LY171555).孤束核后部的多巴胺D2受体介导喹吡罗(LY171555)的中枢升压作用。
Brain Res Bull. 1990 Jan;24(1):97-103. doi: 10.1016/0361-9230(90)90292-8.

引用本文的文献

1
Systemic hypotensive effects of testosterone are androgen structure-specific and neuronal nitric oxide synthase-dependent.睾酮的全身性降压作用具有雄激素结构特异性且依赖神经元型一氧化氮合酶。
Am J Physiol Regul Integr Comp Physiol. 2015 Jul 15;309(2):R189-95. doi: 10.1152/ajpregu.00110.2015. Epub 2015 May 6.
2
Roles of dopaminergic d(1) and d(2) receptors in catecholamine release from the rat adrenal medulla.多巴胺 D1 和 D2 受体在大鼠肾上腺髓质儿茶酚胺释放中的作用。
Korean J Physiol Pharmacol. 2008 Feb;12(1):13-23. doi: 10.4196/kjpp.2008.12.1.13. Epub 2008 Feb 28.
3
Role of the renin-angiotensin system in the compensation of quinpirole-induced blood pressure decrease.
肾素-血管紧张素系统在喹吡罗诱导的血压降低代偿中的作用。
Naunyn Schmiedebergs Arch Pharmacol. 2003 May;367(5):427-33. doi: 10.1007/s00210-003-0740-5. Epub 2003 Apr 23.
4
A nitric oxide-dopamine link pathway in organum vasculosum laminae terminalis of rat brain exerts control over blood pressure.大鼠脑终板血管器中的一氧化氮-多巴胺连接通路对血压起调控作用。
Br J Pharmacol. 2001 Apr;132(7):1524-30. doi: 10.1038/sj.bjp.0703948.
5
In vivo venodilator action of fenoldopam, a dopamine D(1)-receptor agonist.多巴胺 D(1) 受体激动剂非诺多泮的体内静脉扩张作用。
Br J Pharmacol. 2000 Mar;129(5):853-8. doi: 10.1038/sj.bjp.0703119.
6
Radioligand binding and autoradiographic analysis of dopamine receptors in the human heart.人类心脏中多巴胺受体的放射性配体结合及放射自显影分析
Naunyn Schmiedebergs Arch Pharmacol. 1993 Feb;347(2):147-54. doi: 10.1007/BF00169260.
7
Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: in vivo microdialysis studies.多巴胺受体配体诱导大鼠黑质细胞外谷氨酸和天冬氨酸水平的变化:体内微透析研究
Neurochem Res. 1995 Feb;20(2):159-69. doi: 10.1007/BF00970540.
8
Dopamine antagonist effects on locomotor activity in naive and ethanol-treated FAST and SLOW selected lines of mice.
Psychopharmacology (Berl). 1995 Mar;118(1):28-36. doi: 10.1007/BF02245246.
9
The role of DA1- and DA2-receptors in the control of blood pressure.DA1和DA2受体在血压调控中的作用。
Br J Clin Pharmacol. 1990;30 Suppl 1(Suppl 1):61S-68S. doi: 10.1111/j.1365-2125.1990.tb05470.x.